Catalyst Clinical Services Official is India's largest clinical research and pharmacovigilance training and certification organization, committed to advancing healthcare through high-quality clinical trial services. With a focus on innovation, accuracy, and efficiency, CATALYST provides comprehensive clinical research solutions to the pharmaceutical, biotechnology, and medical device industries worldwide. The company offers end-to-end clinical trial management, including project management, clinical trial operations, data management, regulatory services, medical writing, and clinical research and pharmacovigilance training.
To date, more than 12,000 personnel across 35+ countries have participated in various specialized training programs offered by CATALYST. The core team consists of experienced clinical research professionals with expertise in conducting ICH-GCP trials across diverse therapeutic areas. Additionally, CATALYST has been recognized for its achievements, including winning the best scientific poster award at the "First Asia Pacific Lung Cancer Conference" in 2004 and receiving Clinical Excellency Awards from renowned pharmaceutical companies. The University of Oxford in London has entrusted CATALYST with the responsibility of setting up and overseeing a cancer clinical trials network in India and the UK. As a seasoned player in the education industry, CATALYST presents a compelling opportunity for venture capital investment. The company's partnerships and accolades underscore its potential for growth and impact in the field of clinical research and pharmacovigilance. With its strong track record and specialized services, CATALYST is well-positioned to transform innovative ideas into life-changing therapies, presenting an enticing prospect for potential investors.There is no investment information
No recent news or press coverage available for Catalyst Clinical Services Official.